InSpek

InSpek is poised to redefine the field of bio-process monitoring with its cutting-edge integrated photonic sensor technology. Founded in 2021 and headquartered in France, the company aims to enhance the accessibility of therapies, bridging a significant gap in the biopharmaceutical landscape. Its mission is succinctly captured in its slogan: "Improving the access to therapies through enhanced (bio)process monitoring, with integrated photonic sensors."

The venture has already demonstrated substantial promise, securing a €3.50M grant investment as of 01 September 2024. This financial boost underscores confidence from notable investors, including Breega, Quantonation, and Wind. By focusing on the development of revolutionary biological and chemical monitoring systems, InSpek presents a compelling opportunity for investors seeking innovation in the biotech industry. This startup is well-positioned to make significant strides in transforming therapeutic monitoring standards worldwide.